Review the current Cardiology Research Studies
An International, Double-blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) (DELIVER)*
Contact: Karen Evans, RN
Rhode Island Diastolic Dysfunction-Heart Failure (RIDD-HF)*
Contact: Melanie Parent
IL-1B signaling promotes atherosclerotic calcification and cardiovascular risk
Contact: Celia Butler
* Links will take you outside of the Department of Veterans Affairs Website. VA does not endorse and is not responsible for the content of the linked Websites. The link will open in a new window.
Emails are not secure. Do not send personal or medical information over the internet.